dr. charles ryan discusses sequencing prechemotherapy castration-resistant prostate cancer therapies
Published 12 years ago • 503 plays • Length 2:06Download video MP4
Download video MP3
Similar videos
-
1:12
dr. charles ryan discusses imaagen trial update for prostate cancer
-
2:09
dr. charles ryan discusses abiraterone and enzalutamide for mcrpc
-
1:22
dr. charles ryan discusses neoadjuvant abiraterone acetate
-
0:56
dr. charles j. ryan on patients with mcrpc treated with abiraterone
-
1:49
dr. ryan on bone-targeting agents for patients with prostate cancer
-
9:42
dr. shore on therapy combination and sequencing in castration-resistant prostate cancer
-
1:05:07
january 8, 2019 - charles ryan, md
-
1:15
dr. ryan on prescribing preferences in prostate cancer and rcc
-
1:16
dr. charles ryan on the cou-aa-302 abiraterone acetate interim analysis results
-
1:16:17
drs. charles ryan and alicia morgans talk about: metastatic castration-resistant prostate cancer.
-
1:09
use of ar-509 in prostate cancer
-
1:14
dr. ryan discusses the unblinding of the cou-aa-302 trial
-
0:52
dr. lawrence karsh on treatment sequencing in metastatic castration-resistant prostate cancer
-
5:52
clinical trials in non-metastatic crpc
-
15:38
expert prostate discussion: clinical diagnostics, genomics, systemic and radiological treatment
-
6:59
prechemotherapy treatment strategies in castration-resistant prostate cancer
-
2:01
ncrna sequencing from castration-resistant prostate cancer patients | protocol preview
-
5:37
oral hormonal agents for metastatc castration-resistant prostate cancer
-
5:32
clinical trial challenges in metastatic crpc